Isolation of the novel phage SAP71 and its potential use against Staphylococcus aureus in an atopic dermatitis mouse model
Atopic dermatitis (AD) is accompanied by changes in skin microbiota, in which abnormal colonization of Staphylococcus aureus is particularly common. The antibiotic treatment is prone to destroy the commensal bacterial community, further exacerbating the microbiome dysbiosis. Elimination of S. aureus...
Saved in:
| Published in | Virus genes |
|---|---|
| Main Authors | , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
05.09.2024
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Atopic dermatitis (AD) is accompanied by changes in skin microbiota, in which abnormal colonization of Staphylococcus aureus is particularly common. The antibiotic treatment is prone to destroy the commensal bacterial community, further exacerbating the microbiome dysbiosis. Elimination of S. aureus through phage-targeted therapies presents a promising method in the treatment strategy of AD. In this study, we isolated a novel phage SAP71, which specifically lysed S. aureus. Genome sequencing showed that SAP71 contained no virulence, lysogenic, or antimicrobial resistance genes, making this lytic phage a potential agent for phage therapy. Moreover, we demonstrated that phage SAP71 was able to significantly improve the skin lesions, reduce the bacterial loads in the skin, and prevent the development of AD-like skin pathological changes in an AD model. In short, phage SAP71 was demonstrated to effectively treat S. aureus infection in AD, which provided a theoretical basis for the clinical phage therapy of AD. |
|---|---|
| AbstractList | Atopic dermatitis (AD) is accompanied by changes in skin microbiota, in which abnormal colonization of Staphylococcus aureus is particularly common. The antibiotic treatment is prone to destroy the commensal bacterial community, further exacerbating the microbiome dysbiosis. Elimination of S. aureus through phage-targeted therapies presents a promising method in the treatment strategy of AD. In this study, we isolated a novel phage SAP71, which specifically lysed S. aureus. Genome sequencing showed that SAP71 contained no virulence, lysogenic, or antimicrobial resistance genes, making this lytic phage a potential agent for phage therapy. Moreover, we demonstrated that phage SAP71 was able to significantly improve the skin lesions, reduce the bacterial loads in the skin, and prevent the development of AD-like skin pathological changes in an AD model. In short, phage SAP71 was demonstrated to effectively treat S. aureus infection in AD, which provided a theoretical basis for the clinical phage therapy of AD. Atopic dermatitis (AD) is accompanied by changes in skin microbiota, in which abnormal colonization of Staphylococcus aureus is particularly common. The antibiotic treatment is prone to destroy the commensal bacterial community, further exacerbating the microbiome dysbiosis. Elimination of S. aureus through phage-targeted therapies presents a promising method in the treatment strategy of AD. In this study, we isolated a novel phage SAP71, which specifically lysed S. aureus. Genome sequencing showed that SAP71 contained no virulence, lysogenic, or antimicrobial resistance genes, making this lytic phage a potential agent for phage therapy. Moreover, we demonstrated that phage SAP71 was able to significantly improve the skin lesions, reduce the bacterial loads in the skin, and prevent the development of AD-like skin pathological changes in an AD model. In short, phage SAP71 was demonstrated to effectively treat S. aureus infection in AD, which provided a theoretical basis for the clinical phage therapy of AD.Atopic dermatitis (AD) is accompanied by changes in skin microbiota, in which abnormal colonization of Staphylococcus aureus is particularly common. The antibiotic treatment is prone to destroy the commensal bacterial community, further exacerbating the microbiome dysbiosis. Elimination of S. aureus through phage-targeted therapies presents a promising method in the treatment strategy of AD. In this study, we isolated a novel phage SAP71, which specifically lysed S. aureus. Genome sequencing showed that SAP71 contained no virulence, lysogenic, or antimicrobial resistance genes, making this lytic phage a potential agent for phage therapy. Moreover, we demonstrated that phage SAP71 was able to significantly improve the skin lesions, reduce the bacterial loads in the skin, and prevent the development of AD-like skin pathological changes in an AD model. In short, phage SAP71 was demonstrated to effectively treat S. aureus infection in AD, which provided a theoretical basis for the clinical phage therapy of AD. |
| Author | Yang, Xin Lu, Mao Yang, Kailang Shu, Yi Jia, Xu Luan, Guangxin Geng, Huaixin Zhang, Wen Xiang, Jingheng Zou, Chenghui |
| Author_xml | – sequence: 1 givenname: Huaixin surname: Geng fullname: Geng, Huaixin organization: Non-Coding RNA and Drug Discovery Key Laboratory of Sichuan Province, Chengdu Medical College, Chengdu, Sichuan, China – sequence: 2 givenname: Xin surname: Yang fullname: Yang, Xin organization: Non-Coding RNA and Drug Discovery Key Laboratory of Sichuan Province, Chengdu Medical College, Chengdu, Sichuan, China – sequence: 3 givenname: Chenghui surname: Zou fullname: Zou, Chenghui organization: Department of Dermatovenereology, Clinical Medical College and the First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China – sequence: 4 givenname: Wen surname: Zhang fullname: Zhang, Wen organization: Department of Dermatovenereology, Clinical Medical College and the First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China – sequence: 5 givenname: Jingheng surname: Xiang fullname: Xiang, Jingheng organization: Non-Coding RNA and Drug Discovery Key Laboratory of Sichuan Province, Chengdu Medical College, Chengdu, Sichuan, China – sequence: 6 givenname: Kailang surname: Yang fullname: Yang, Kailang organization: Non-Coding RNA and Drug Discovery Key Laboratory of Sichuan Province, Chengdu Medical College, Chengdu, Sichuan, China – sequence: 7 givenname: Yi surname: Shu fullname: Shu, Yi organization: Non-Coding RNA and Drug Discovery Key Laboratory of Sichuan Province, Chengdu Medical College, Chengdu, Sichuan, China – sequence: 8 givenname: Guangxin surname: Luan fullname: Luan, Guangxin email: guangxin.luan@cmc.edu.cn organization: Non-Coding RNA and Drug Discovery Key Laboratory of Sichuan Province, Chengdu Medical College, Chengdu, Sichuan, China. guangxin.luan@cmc.edu.cn – sequence: 9 givenname: Xu surname: Jia fullname: Jia, Xu email: jiaxu@cmc.edu.cn organization: Non-Coding RNA and Drug Discovery Key Laboratory of Sichuan Province, Chengdu Medical College, Chengdu, Sichuan, China. jiaxu@cmc.edu.cn – sequence: 10 givenname: Mao surname: Lu fullname: Lu, Mao email: 2680550218@qq.com organization: Department of Dermatovenereology, Clinical Medical College and the First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China. 2680550218@qq.com |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39235696$$D View this record in MEDLINE/PubMed |
| BookMark | eNo9kFFLHTEQhUNR6tX2D_Sh5LEvWyezu9nNo4i2gqCggm8hTWa9KbvJuskW9Neb22v7MBwYzjkzfMfsIMRAjH0R8F0AdKdJCJRYATZlBMgKP7CNaDuslGoeD9gGFELVt1IdseOUfgNA32PzkR3VCuuylhv2epXiaLKPgceB5y3xEP_QyOeteSJ-d3bbCW6C4z4nPsdMIXsz8jURN0_Gh5T5XTbz9mWMNlq7Jm7WhYr4UGLc5Dh7yx0tU7mRfeJT3GWn6Gj8xA4HMyb6_K4n7OHy4v78Z3V98-Pq_Oy6sqJvctW6pqkRG3BK9sYNALJTEowgNK5D11olO1JSDJaUED2SG2zdtA5R9E7W9Qn7tu-dl_i8Usp68snSOJpA5RtdF5hKKAAsVtxb7RJTWmjQ8-Ins7xoAXrHXO-Z68Jc_2Wud6Gv7_3rr4nc_8g_yPUb30l_Fw |
| Cites_doi | 10.1016/j.cell.2022.07.003 10.1056/NEJMoa021481 10.1016/j.jid.2016.05.127 10.1128/cmr.00062-22 10.5114/ada.2018.77056 10.20344/amp.11963 10.18176/jiaci.0293 10.1128/spectrum.04384-22 10.1016/j.jaci.2018.11.015 10.1016/s1473-3099(21)00612-5 10.1007/s12016-016-8548-5 10.1016/j.jdermsci.2019.07.001 10.1016/j.cell.2022.11.017 10.1111/j.1365-2133.2010.09743.x 10.1016/j.jaip.2014.04.007 10.36849/JDD.6638 10.1016/j.cell.2023.10.019 10.3389/fmicb.2018.01553 10.4168/aair.2019.11.5.593 10.1016/j.cell.2022.04.024 10.1111/j.1399-3038.2005.00212.x 10.1155/2022/3323201 10.1038/s41598-020-62691-8 10.1016/j.jaci.2015.07.052 10.1046/j.1523-1747.2002.01846.x 10.1093/jac/dkab455 10.1016/j.tim.2017.11.008 10.1111/j.1600-0625.2008.00734.x 10.3390/ijms24032695.17 10.1128/aac.02273-21 10.1111/bjd.17033 10.3390/v13010007 10.1093/nar/gkt1226 10.1093/molbev/msab120 10.1111/1346-8138.16546 10.1046/j.1523-1747.1998.00293.x 10.1111/j.1749-4486.2009.01973.x 10.4062/biomolther.2020.135 10.1038/srep28338 10.1007/s10096-012-1691-x 10.3390/antibiotics12020286 |
| ContentType | Journal Article |
| Copyright | 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. |
| Copyright_xml | – notice: 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. |
| DBID | NPM AAYXX CITATION 7X8 |
| DOI | 10.1007/s11262-024-02106-2 |
| DatabaseName | PubMed CrossRef MEDLINE - Academic |
| DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1572-994X |
| ExternalDocumentID | 10_1007_s11262_024_02106_2 39235696 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: the Natural Science Foundation of Sichuan Province grantid: No. 2022NSFSC0755 |
| GroupedDBID | --- -4W -56 -5G -BR -EM -~C .86 .VR 06C 06D 0R~ 0VY 123 1N0 203 29Q 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2~H 30V 4.4 406 408 409 40D 40E 5RE 5VS 67N 67Z 6NX 78A 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHBH AAHNG AAIAL AAJBT AAJKR AANZL AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTHY ABTKH ABTMW ABWNU ABXPI ACAOD ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPRK ACSNA ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEFQL AEGAL AEGNC AEJHL AEJRE AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BENPR BGNMA BHPHI CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 EBLON EBS EIOEI EPAXT ESBYG F5P FEDTE FERAY FFXSO FIGPU FNLPD FRRFC FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GXS HCIFZ HF~ HG5 HG6 HMJXF HQYDN HRMNR HVGLF I09 IHE IJ- IKXTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KPH LAK LLZTM M4Y M7P MA- NB0 NPM NPVJJ NQJWS NU0 O93 O9G O9I O9J OAM P19 P2P PF0 PT4 PT5 QOK QOR QOS R89 R9I RHV RIG ROL RPX RRX RSV S16 S1Z S27 S3A S3B SAP SBL SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SZN T13 TSG TSK TSV TUC U2A UG4 UOJIU UTJUX VC2 W23 W48 WH7 WJK WK8 Y6R YLTOR Z45 Z7U Z7W Z87 Z8O Z8Q Z91 ZMTXR ZOVNA ~A9 ~EX ~KM AAYXX ACIPQ CITATION 7X8 |
| ID | FETCH-LOGICAL-c184t-5d4432240d968adf0067960a1e2ad72d5c967e961fce91182edfc345d2218d633 |
| ISSN | 0920-8569 1572-994X |
| IngestDate | Sat Oct 26 04:08:02 EDT 2024 Thu Sep 26 20:25:58 EDT 2024 Sat Nov 02 12:07:08 EDT 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Mouse model Atopic dermatitis Phage therapy Staphylococcus aureus |
| Language | English |
| License | 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c184t-5d4432240d968adf0067960a1e2ad72d5c967e961fce91182edfc345d2218d633 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 39235696 |
| PQID | 3100919002 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_3100919002 crossref_primary_10_1007_s11262_024_02106_2 pubmed_primary_39235696 |
| PublicationCentury | 2000 |
| PublicationDate | 2024-Sep-05 2024-09-05 20240905 |
| PublicationDateYYYYMMDD | 2024-09-05 |
| PublicationDate_xml | – month: 09 year: 2024 text: 2024-Sep-05 day: 05 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Virus genes |
| PublicationTitleAlternate | Virus Genes |
| PublicationYear | 2024 |
| References | A Sala-Cunill (2106_CR1) 2018; 28 N Natarelli (2106_CR17) 2023; 24 M Tauber (2106_CR30) 2016; 137 M Niebuhr (2106_CR7) 2008; 17 A Vieira (2106_CR37) 2012; 31 M Horváth (2106_CR23) 2020; 10 H Tomczak (2106_CR40) 2019; 36 S Uyttebroek (2106_CR15) 2022; 22 PY Ong (2106_CR36) 2002; 347 JA Nick (2106_CR12) 2022; 185 PY Ong (2106_CR21) 2014; 2 SA Strathdee (2106_CR14) 2023; 186 M Gupta (2106_CR16) 2022; 21 Y Shimamori (2106_CR18) 2020; 13 A Wright (2106_CR11) 2009; 34 AS Paller (2106_CR3) 2019; 143 T Torres (2106_CR19) 2019; 32 S Federici (2106_CR10) 2022; 185 AJ Hendricks (2106_CR4) 2019; 95 R Overbeek (2106_CR25) 2014; 42 J Kim (2106_CR31) 2019; 11 F Eichenseher (2106_CR8) 2022; 66 L Deng (2106_CR20) 2023; 186 J Arikawa (2106_CR33) 2002; 119 L Marongiu (2106_CR13) 2022; 35 T Nakatsuji (2106_CR39) 2016; 136 K Tamura (2106_CR27) 2021; 38 SS Atshan (2106_CR9) 2023; 12 M Joishy (2106_CR41) 2005; 16 FJ Bath-Hextall (2106_CR6) 2010; 163 H Geng (2106_CR24) 2023; 11 M Mempel (2106_CR34) 1998; 111 SA Park (2106_CR28) 2020; 28 R Miyake (2106_CR32) 2022; 49 B Ding (2106_CR38) 2018; 9 E Li (2106_CR22) 2016; 6 LT Huong Nguyen (2106_CR29) 2022; 2022 JA Geoghegan (2106_CR5) 2018; 26 PY Ong (2106_CR2) 2016; 51 M Tello (2106_CR26) 2022; 77 ML Clausen (2106_CR35) 2019; 180 |
| References_xml | – volume: 185 start-page: 2879 year: 2022 ident: 2106_CR10 publication-title: Cell doi: 10.1016/j.cell.2022.07.003 contributor: fullname: S Federici – volume: 347 start-page: 1151 year: 2002 ident: 2106_CR36 publication-title: N Engl J Med doi: 10.1056/NEJMoa021481 contributor: fullname: PY Ong – volume: 136 start-page: 2192 year: 2016 ident: 2106_CR39 publication-title: J Invest Dermatol doi: 10.1016/j.jid.2016.05.127 contributor: fullname: T Nakatsuji – volume: 35 year: 2022 ident: 2106_CR13 publication-title: Clin Microbiol Rev doi: 10.1128/cmr.00062-22 contributor: fullname: L Marongiu – volume: 36 start-page: 485 year: 2019 ident: 2106_CR40 publication-title: Postepy Dermatol Alergol doi: 10.5114/ada.2018.77056 contributor: fullname: H Tomczak – volume: 32 start-page: 606 year: 2019 ident: 2106_CR19 publication-title: Acta Med Port doi: 10.20344/amp.11963 contributor: fullname: T Torres – volume: 28 start-page: 379 year: 2018 ident: 2106_CR1 publication-title: J Investig Allergol Clin Immunol doi: 10.18176/jiaci.0293 contributor: fullname: A Sala-Cunill – volume: 11 year: 2023 ident: 2106_CR24 publication-title: Microbiol Spectr doi: 10.1128/spectrum.04384-22 contributor: fullname: H Geng – volume: 143 start-page: 26 year: 2019 ident: 2106_CR3 publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2018.11.015 contributor: fullname: AS Paller – volume: 22 start-page: e208 year: 2022 ident: 2106_CR15 publication-title: Lancet Microbe doi: 10.1016/s1473-3099(21)00612-5 contributor: fullname: S Uyttebroek – volume: 51 start-page: 329 year: 2016 ident: 2106_CR2 publication-title: Clin Rev Allergy Immunol doi: 10.1007/s12016-016-8548-5 contributor: fullname: PY Ong – volume: 95 start-page: 56 year: 2019 ident: 2106_CR4 publication-title: J Dermatol Sci doi: 10.1016/j.jdermsci.2019.07.001 contributor: fullname: AJ Hendricks – volume: 186 start-page: 17 year: 2023 ident: 2106_CR14 publication-title: Cell doi: 10.1016/j.cell.2022.11.017 contributor: fullname: SA Strathdee – volume: 163 start-page: 12 year: 2010 ident: 2106_CR6 publication-title: Br J Dermatol doi: 10.1111/j.1365-2133.2010.09743.x contributor: fullname: FJ Bath-Hextall – volume: 2 start-page: 396 year: 2014 ident: 2106_CR21 publication-title: J Allergy Clin Immunol Pract doi: 10.1016/j.jaip.2014.04.007 contributor: fullname: PY Ong – volume: 21 start-page: 1311 year: 2022 ident: 2106_CR16 publication-title: Drugs Dermatol doi: 10.36849/JDD.6638 contributor: fullname: M Gupta – volume: 186 start-page: 5375 year: 2023 ident: 2106_CR20 publication-title: Cell doi: 10.1016/j.cell.2023.10.019 contributor: fullname: L Deng – volume: 9 start-page: 1553 year: 2018 ident: 2106_CR38 publication-title: Front Microbiol doi: 10.3389/fmicb.2018.01553 contributor: fullname: B Ding – volume: 11 start-page: 593 year: 2019 ident: 2106_CR31 publication-title: Allergy Asthma Immunol Res doi: 10.4168/aair.2019.11.5.593 contributor: fullname: J Kim – volume: 185 start-page: 1860 year: 2022 ident: 2106_CR12 publication-title: Cell doi: 10.1016/j.cell.2022.04.024 contributor: fullname: JA Nick – volume: 16 start-page: 283 year: 2005 ident: 2106_CR41 publication-title: Pediatr Allergy Immunol doi: 10.1111/j.1399-3038.2005.00212.x contributor: fullname: M Joishy – volume: 2022 start-page: 3323201 year: 2022 ident: 2106_CR29 publication-title: Evid Based Complement Alternat Med doi: 10.1155/2022/3323201 contributor: fullname: LT Huong Nguyen – volume: 10 start-page: 5891 year: 2020 ident: 2106_CR23 publication-title: Sci Rep doi: 10.1038/s41598-020-62691-8 contributor: fullname: M Horváth – volume: 137 start-page: 1272 year: 2016 ident: 2106_CR30 publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2015.07.052 contributor: fullname: M Tauber – volume: 119 start-page: 433 year: 2002 ident: 2106_CR33 publication-title: J Invest Dermatol doi: 10.1046/j.1523-1747.2002.01846.x contributor: fullname: J Arikawa – volume: 77 start-page: 843 year: 2022 ident: 2106_CR26 publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkab455 contributor: fullname: M Tello – volume: 26 start-page: 484 year: 2018 ident: 2106_CR5 publication-title: Trends Microbiol doi: 10.1016/j.tim.2017.11.008 contributor: fullname: JA Geoghegan – volume: 17 start-page: 953 year: 2008 ident: 2106_CR7 publication-title: Exp Dermatol doi: 10.1111/j.1600-0625.2008.00734.x contributor: fullname: M Niebuhr – volume: 24 start-page: 2695 year: 2023 ident: 2106_CR17 publication-title: Int J Mol Sci doi: 10.3390/ijms24032695.17 contributor: fullname: N Natarelli – volume: 66 year: 2022 ident: 2106_CR8 publication-title: Antimicrob Agents Chemother doi: 10.1128/aac.02273-21 contributor: fullname: F Eichenseher – volume: 180 start-page: 181 year: 2019 ident: 2106_CR35 publication-title: Br J Dermatol doi: 10.1111/bjd.17033 contributor: fullname: ML Clausen – volume: 13 start-page: 7 year: 2020 ident: 2106_CR18 publication-title: Viruses doi: 10.3390/v13010007 contributor: fullname: Y Shimamori – volume: 42 start-page: D206 year: 2014 ident: 2106_CR25 publication-title: Nucleic Acids Res doi: 10.1093/nar/gkt1226 contributor: fullname: R Overbeek – volume: 38 start-page: 3022 year: 2021 ident: 2106_CR27 publication-title: Mol Biol Evol doi: 10.1093/molbev/msab120 contributor: fullname: K Tamura – volume: 49 start-page: 1148 year: 2022 ident: 2106_CR32 publication-title: J Dermatol doi: 10.1111/1346-8138.16546 contributor: fullname: R Miyake – volume: 111 start-page: 452 year: 1998 ident: 2106_CR34 publication-title: J Invest Dermatol doi: 10.1046/j.1523-1747.1998.00293.x contributor: fullname: M Mempel – volume: 34 start-page: 349 year: 2009 ident: 2106_CR11 publication-title: Clin Otolaryngol doi: 10.1111/j.1749-4486.2009.01973.x contributor: fullname: A Wright – volume: 28 start-page: 542 year: 2020 ident: 2106_CR28 publication-title: Biomol Ther (Seoul) doi: 10.4062/biomolther.2020.135 contributor: fullname: SA Park – volume: 6 start-page: 28338 year: 2016 ident: 2106_CR22 publication-title: Sci Rep doi: 10.1038/srep28338 contributor: fullname: E Li – volume: 31 start-page: 3241 year: 2012 ident: 2106_CR37 publication-title: Eur J Clin Microbiol Infect Dis doi: 10.1007/s10096-012-1691-x contributor: fullname: A Vieira – volume: 12 start-page: 286 year: 2023 ident: 2106_CR9 publication-title: Antibiotics (Basel) doi: 10.3390/antibiotics12020286 contributor: fullname: SS Atshan |
| SSID | ssj0008824 |
| Score | 2.41172 |
| Snippet | Atopic dermatitis (AD) is accompanied by changes in skin microbiota, in which abnormal colonization of Staphylococcus aureus is particularly common. The... |
| SourceID | proquest crossref pubmed |
| SourceType | Aggregation Database Index Database |
| Title | Isolation of the novel phage SAP71 and its potential use against Staphylococcus aureus in an atopic dermatitis mouse model |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/39235696 https://www.proquest.com/docview/3100919002 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELegExIviPG18SUj8RZlSpzEiR87tKpDoyDRQuElcmxni4SSqksQ7K_n_NFkpSANXqLKqs_q3a-X39l3PoRex1RfekJCXzIIV4FSFz5LRObTsuCCZiLNzFHMuxmdLuK3y2Q5tLkz1SVtcSSu_lhX8j9WhTGwq66S_QfL9kJhAD6DfeEJFobnjWx8CuJ7yqcZZN18V9-81YVOxPk4_pCG_dnAqml1XhAYpLtUHj_nFfBCTTVBzfA-a4ToLj3erVVnEmThXw_R-KoSnlSW1Fa6a46ea3rnXOe0n6o1TDrXTrPP5lHWhUw7Xv2oevx9cZvTy2Hoa9PZU3-YcdFVO_vYn12pmtuYILHJvEqu-9KU-IzZBMwjtTu2470DV80cEkp8IxECUurKI7euyp69zyeLs7N8frKc30Z7BLxMNkJ748nx8ax_EUPwYJIKNmu6milbOfn7Gtu85C_BhiEd8_vonosW8Niafh_dUvUDdMf2D_35EF31AMBNiQEA2AAAGwBgAwAMAMAAANwDAIMRsQMA3gYAtgDAVQ3TsAUAHgCADQCwAcAjtJiczN9MfddMwxcQxLd-IuM40vxNMppxWQZmBzHgoSJcpkQmgtFUMRqWQjEddSpZiihOJAESKGkUPUajuqnVAcIQcwcRC0AK43FIeFaoqEhYzIMyFFFJD5G3UWW-snem5MPt2FrxOSg-N4rPySF6tdF2Dq5Nn1fxWsHvyfXZE4O1AvjOE2uGXh7Q-iihjD69wexn6O6Az-do1K479QKoZFu8dJD5BSZtcuo |
| link.rule.ids | 315,783,787,27938,27939 |
| linkProvider | Library Specific Holdings |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Isolation+of+the+novel+phage+SAP71+and+its+potential+use+against+Staphylococcus+aureus+in+an+atopic+dermatitis+mouse+model&rft.jtitle=Virus+genes&rft.au=Geng%2C+Huaixin&rft.au=Yang%2C+Xin&rft.au=Zou%2C+Chenghui&rft.au=Zhang%2C+Wen&rft.date=2024-09-05&rft.issn=1572-994X&rft.eissn=1572-994X&rft_id=info:doi/10.1007%2Fs11262-024-02106-2&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0920-8569&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0920-8569&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0920-8569&client=summon |